Works matching IS 02698811 AND DT 2023 AND VI 37 AND IP 12

Results: 10

Abuse potential assessment of the dual orexin receptor antagonist daridorexant in rats.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 12, p. 1249, doi. 10.1177/02698811231215415

By:

Steiner, Michel A;
Toeroek-Schafroth, Michael;
Giusepponi, Maria Elena;
Dacome, Lisa;
Tessari, Michela

Publication type:

Article

Value-based decision-making predicts alcohol use and related problems in young men.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 12, p. 1218, doi. 10.1177/02698811231212151

By:

Petzold, Johannes;
Hentschel, Angela;
Chen, Hao;
Kuitunen-Paul, Sören;
London, Edythe D;
Heinz, Andreas;
Smolka, Michael N

Publication type:

Article

The 5-HT7 receptor system as a treatment target for mood and anxiety disorders: A systematic review.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 12, p. 1167, doi. 10.1177/02698811231211228

By:

Gottlieb, Natalie;
Li, Tse-Yi;
Young, Allan H;
Stokes, Paul RA

Publication type:

Article

Hyperdopaminergia in rats is associated with reverse effort-cost dependent performance.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 12, p. 1238, doi. 10.1177/02698811231211225

By:

Savchenko, Artem;
Belozertseva, Irina;
Leo, Damiana;
Sukhanov, Ilya

Publication type:

Article

Failure of the dual orexin receptor antagonist suvorexant to engender drug discrimination in rats.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 12, p. 1261, doi. 10.1177/02698811231211176

By:

Steiner, Michel A;
Toeroek-Schafroth, Michael;
Dacome, Lisa;
Tessari, Michela

Publication type:

Article

Modulation of functional networks related to the serotonin neurotransmitter system by citalopram: Evidence from a multimodal neuroimaging study.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 12, p. 1209, doi. 10.1177/02698811231211154

By:

Boucherie, Daphne E;
Reneman, Liesbeth;
Booij, Jan;
Martins, Daniel;
Dipasquale, Ottavia;
Schrantee, Anouk

Publication type:

Article

The potential for medicinal cannabis to help manage challenging behaviour in people with intellectual disability: A perspective review.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 12, p. 1201, doi. 10.1177/02698811231209192

By:

Korb, Laura;
Tromans, Samuel;
Perera, Bhathika;
Khan, Nagina;
Burrows, Lisa;
Laugharne, Richard;
Hassiotis, Angela;
Allgar, Victoria;
Efron, Daryl;
Maidment, Ian;
Shankar, Rohit

Publication type:

Article

Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 12, p. 1190, doi. 10.1177/02698811231200882

By:

Ona, Genís;
Reverte, Ingrid;
Rossi, Giordano N;
dos Santos, Rafael G;
Hallak, Jaime EC;
Colomina, Maria Teresa;
Bouso, José Carlos

Publication type:

Article

Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 12, p. 1182, doi. 10.1177/02698811231200880

By:

Gully, Brian J.;
Eaton, Erica;
Capone, Christy;
Haass-Koffler, Carolina L.

Publication type:

Article

Acute administration of alprazolam, alcohol and their combination on cognitive performance and mood: A randomised, double-blind, placebo-controlled study.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 12, p. 1227, doi. 10.1177/02698811231200878

By:

Aitken, Blair;
Hayley, Amie C;
Ford, Talitha C;
Geier, Lauren;
Shiferaw, Brook A;
Downey, Luke A

Publication type:

Article